Bessemer Group Inc Biogen Inc. Transaction History

Bessemer Group Inc

  • $60.7 Billion
  • Q3 2024

A detailed history of Bessemer Group Inc transactions in Biogen Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 2,692 shares of BIIB stock, worth $424,501. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,692
Previous 3,331 19.18%
Holding current value
$424,501
Previous $772,000 32.38%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$189.07 - $236.8 $120,815 - $151,315
-639 Reduced 19.18%
2,692 $522,000
Q2 2024

Aug 13, 2024
BUY
$190.52 - $236.72 $52,774 - $65,571
277 Added 9.07%
3,331 $772,000
Q1 2024

May 13, 2024
BUY
$212.02 - $267.71 $9,116 - $11,511
43 Added 1.43%
3,054 $657,000
Q4 2023

Feb 09, 2024
SELL
$222.59 - $267.94 $457,422 - $550,616
-2,055 Reduced 40.56%
3,011 $779,000
Q3 2023

Nov 13, 2023
SELL
$253.3 - $285.89 $84,348 - $95,201
-333 Reduced 6.17%
5,066 $1.3 Million
Q2 2023

Aug 10, 2023
BUY
$275.25 - $318.06 $292,866 - $338,415
1,064 Added 24.54%
5,399 $1.54 Million
Q1 2023

May 10, 2023
SELL
$256.56 - $292.34 $14,110 - $16,078
-55 Reduced 1.25%
4,335 $1.21 Million
Q4 2022

Feb 13, 2023
SELL
$252.44 - $306.72 $42,914 - $52,142
-170 Reduced 3.73%
4,390 $1.22 Million
Q3 2022

Nov 09, 2022
BUY
$194.69 - $268.46 $171,911 - $237,050
883 Added 24.01%
4,560 $1.22 Million
Q2 2022

Aug 10, 2022
SELL
$187.54 - $223.02 $1,875 - $2,230
-10 Reduced 0.27%
3,677 $750,000
Q1 2022

May 12, 2022
BUY
$193.77 - $244.14 $165,479 - $208,495
854 Added 30.14%
3,687 $777,000
Q4 2021

Jan 27, 2022
BUY
$223.92 - $287.77 $155,624 - $200,000
695 Added 32.51%
2,833 $679,000
Q3 2021

Nov 12, 2021
SELL
$282.99 - $369.05 $77,256 - $100,750
-273 Reduced 11.32%
2,138 $606,000
Q2 2021

Aug 06, 2021
BUY
$259.0 - $414.71 $67,081 - $107,409
259 Added 12.04%
2,411 $834,000
Q1 2021

May 13, 2021
SELL
$242.95 - $284.63 $447,999 - $524,857
-1,844 Reduced 46.15%
2,152 $602,000
Q4 2020

Feb 09, 2021
SELL
$236.26 - $355.63 $209,562 - $315,443
-887 Reduced 18.17%
3,996 $978,000
Q3 2020

Nov 12, 2020
SELL
$264.77 - $305.71 $802,253 - $926,301
-3,030 Reduced 38.29%
4,883 $1.39 Million
Q2 2020

Aug 05, 2020
BUY
$258.66 - $342.55 $1.06 Million - $1.4 Million
4,081 Added 106.5%
7,913 $2.12 Million
Q1 2020

Apr 30, 2020
SELL
$268.85 - $341.04 $72,320 - $91,739
-269 Reduced 6.56%
3,832 $1.21 Million
Q4 2019

Feb 04, 2020
BUY
$220.06 - $304.07 $106,068 - $146,561
482 Added 13.32%
4,101 $1.22 Million
Q3 2019

Nov 07, 2019
SELL
$217.44 - $243.88 $41,313 - $46,337
-190 Reduced 4.99%
3,619 $843,000
Q2 2019

Jul 19, 2019
BUY
$219.29 - $241.72 $355,688 - $392,069
1,622 Added 74.17%
3,809 $891,000
Q1 2019

May 13, 2019
BUY
$216.71 - $338.96 $185,070 - $289,471
854 Added 64.07%
2,187 $518,000
Q4 2018

Feb 12, 2019
BUY
$278.5 - $352.75 $106,108 - $134,397
381 Added 40.02%
1,333 $401,000
Q3 2018

Nov 06, 2018
SELL
$293.51 - $383.83 $11,740 - $15,353
-40 Reduced 4.03%
952 $336,000
Q2 2018

Jul 25, 2018
SELL
$257.52 - $306.91 $20,601 - $24,552
-80 Reduced 7.46%
992 $288,000
Q1 2018

May 10, 2018
SELL
$260.13 - $367.91 $4,942 - $6,990
-19 Reduced 1.74%
1,072 $293,000
Q4 2017

Jan 30, 2018
BUY
$307.64 - $344.58 $10,152 - $11,371
33 Added 3.12%
1,091 $347,000
Q3 2017

Nov 03, 2017
BUY
$281.15 - $329.69 $297,456 - $348,812
1,058
1,058 $331,000

Others Institutions Holding BIIB

# of Institutions
1,037
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email